This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leonhardt, A.
Right arrow Articles by Seyberth, H. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leonhardt, A.
Right arrow Articles by Seyberth, H. W.
Related Collections
Right arrow Therapeutics & Toxicology

PEDIATRICS Vol. 111 No. 1 January 2003, pp. e77-e81

ELECTRONIC ARTICLE

Low-Dose Aspirin in Pregnancy: Maternal and Neonatal Aspirin Concentrations and Neonatal Prostanoid Formation

Andreas Leonhardt, MD*, Stefanie Bernert, MD*, Bernhard Watzer*, Gabriele Schmitz-Ziegler, MD{ddagger} and Hannsjörg W. Seyberth, MD*

* Departments of Pediatrics
{ddagger} Obstetrics and Gynecology, Philipp’s University, Marburg, Germany

--> Objective. To evaluate maternal and neonatal plasma concentrations of acetylsalicylic acid and salicylic acid and the neonatal endogenous prostanoid formation during low-dose aspirin prophylaxis (LDA; 100 mg daily) in pregnant women.

Methods. Concentrations of acetylsalicylic acid and salicylic acid in maternal plasma after at least 4 weeks of LDA (n = 14) and in umbilical cord plasma of newborns after maternal LDA (n = 7) were determined by gas chromatography–mass spectrometry. Platelet and renal formation of thromboxane A2 and the formation of prostaglandin E2 and prostacyclin were evaluated in vivo by quantification of index metabolites in plasma and urine by gas chromatography–mass spectrometry in neonates after maternal LDA (n = 14) and in a control group.

Results. In the pregnant women, acetylsalicylic acid and salicylic acid concentrations rapidly increased after ingestion of LDA. Acetylsalicylic acid was completely eliminated within 4 hours, whereas salicylic acid was detected with low concentrations at 18 and 21 hours after dosing. In the neonates, acetylsalicylic acid was not detected. Salicylic acid was detected in 1 infant only. Platelet thromboxane A2 formation in the newborn infants was significantly suppressed but recovered within 2 to 3 days after discontinuation of LDA. Renal thromboxane A2 formation and the formation of prostaglandin E2 and prostacyclin were not affected by LDA.

Conclusion. In pregnant women who are treated with LDA, acetylsalicylic acid is not completely inactivated in the portal circulation but reaches the uteroplacental circulation and exerts antiplatelet effects in the fetus and newborn.

Key Words: low-dose aspirin • prostanoids • newborn infant • mass spectrometry

Abbreviations: LDA, low-dose aspirin • Tx, thromboxane • PG, prostaglandin • GC-MS, gas chromatography-mass spectrometry

Received for publication May 21, 2002; Accepted Sep 13, 2002.